ADDUCTS OF ORGANOTIN(IV), TIN(IV) AND TIN(II) HALIDES WITH 1-METHYL-IMIDAZOLINE-2(3H)-THIONE (HMIMT) AND IMIDAZOLINE-2(1,3H)-THIONE (HIMT) - SYNTHESIS, SPECTROSCOPIC (IR, MOSSBAUER AND H-1, C-13, SN-119 NMR) STUDIES AND IN-VITRO ANTITUMOR-ACTIVITY
D. Kovalademertzi et al., ADDUCTS OF ORGANOTIN(IV), TIN(IV) AND TIN(II) HALIDES WITH 1-METHYL-IMIDAZOLINE-2(3H)-THIONE (HMIMT) AND IMIDAZOLINE-2(1,3H)-THIONE (HIMT) - SYNTHESIS, SPECTROSCOPIC (IR, MOSSBAUER AND H-1, C-13, SN-119 NMR) STUDIES AND IN-VITRO ANTITUMOR-ACTIVITY, Inorganica Chimica Acta, 239(1-2), 1995, pp. 177-183
The reactions of 1-methyl-imidazoline-2(3H)-thione (Hmimt) and imidazo
line-2(1,3H) -thione (Himt) with organotin(IV), tin(IV) and tin(lI) ha
lides were studied. Ten novel adducts were prepared and characterised
by elemental analysis, conductivity measurements, IR, far-IR, H-1 NMR,
C-13 NMR,Sn-119 NMR and Mossbauer spectroscopy. The ligands behave as
monodentate and exhibit sulfur coordination. The structure of the com
plexes, in the solid state, is discussed in terms of the Mossbauer qua
drupole splitting and the tin-ligand stretching vibrations in the IR a
nd far-IR spectra. The behaviour of the adducts upon dissolution to D2
O and CDCl3 is also discussed. Octahedral dimeric and monomeric stereo
chemistries are assigned for organotin(IV) and tin(IV) adducts in the
solid state. The in vitro antitumour activity against six human cell l
ines, MCF-7, EVSA (two breast cancers), WiDr (a colon cancer), IGROV (
an ovarian cancer), M19MEL (a melanoma) and A498 (a renal cancer) for
the adducts [SnBuCl(3)(Hmimt)](2), [SnMeCl(3)(Himt)](2) and SnMe(2)Cl(
2)(Himt)(2) is reported.